Prescription RequiredGefitinib 250 mg (Geftinat) is a targeted anticancer medicine used to treat non-small cell lung cancer (NSCLC) with specific EGFR (epidermal growth factor receptor) mutations. It works by blocking the EGFR protein that promotes the growth and spread of cancer cells. By targeting this pathway, Gefitinib helps slow tumour growth and improve disease control.
| Generic name | Gefitinib |
| Strength | 250 mg |
| Manufacturer | Natco |
| Package size | 30 Tablets |
| Used for | Non-small cell lung cancer (NSCLC) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Gefitinib is an EGFR (epidermal growth factor receptor) inhibitor. It blocks the EGFR protein on cancer cells, preventing signals that stimulate cell growth and division. This slows the growth and spread of cancer cells while helping control the progression of the disease.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
